The CMN‐SMP inclusion complex displayed significantly enhanced anticancer activity against Caco‐2 and SW480 cells, with anticancer potency derived mostly from the induction of cellular apoptosis of tumor cells. This evidence concerns the gene FAM53B and neoplasm.